Medicare Enrolled
Dr. Ana Benitez-Graham, M.D.
Dermatology · Mebane, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Benitez-Graham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benitez-Graham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Benitez-Graham
Dr. Ana Benitez-Graham is a dermatology specialist in Mebane, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Benitez-Graham performed 4,229 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Benitez-Graham received a total of $21,573 from 45 pharmaceutical and/or device companies across 1269 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Benitez-Graham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 29% volume in NC
$21,573 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,229
Medicare services
Top 29% in NC for dermatology
Not available
Unique patients (not deduplicated)
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,562 | $5 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
664 | $78 | $246 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
568 | $38 | $128 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
338 | $56 | $173 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
298 | $66 | $194 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
137 | $63 | $215 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
99 | $218 | $582 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
92 | $36 | $96 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $97 | $320 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
70 | $117 | $323 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
38 | $63 | $329 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
34 | $45 | $139 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
26 | $105 | $535 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
26 | $218 | $595 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 26 | $197 | $606 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
24 | $10 | $27 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
23 | $92 | $469 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
22 | $73 | $217 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
21 | $101 | $512 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
20 | $147 | $408 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $36 | $108 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
18 | $54 | $185 |
| Intermediate wound repair, 7.6-12.5 cm This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that measures between 7.6 and 12.5 centimeters. It includes cleaning the wound and closing it with sutures to promote healing. |
17 | $251 | $641 |
| Surgical removal of skin cancer, 2.1-3.0 cm Surgical excision of a cancerous skin growth measuring 2.1 to 3.0 centimeters from the scalp, neck, hands, feet, or genitals. |
11 | $111 | $568 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,573
Total received (2018-2024)
Avg $3,082/year across 7 years
Top 10% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
1,269
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,078
2023
$3,782
2022
$3,630
2021
$2,386
2020
$1,695
2019
$2,549
2018
$1,452
Payments by company (2024)
ABBVIE INC.
$1,172
Janssen Biotech, Inc.
$628
E.R. Squibb & Sons, L.L.C.
$592
Arcutis Biotherapeutics, Inc.
$489
Regeneron Healthcare Solutions, Inc.
$466
Novartis Pharmaceuticals Corporation
$372
GENZYME CORPORATION
$333
Galderma Laboratories, L.P.
$317
Amgen Inc.
$316
UCB, Inc.
$285
Dermavant Sciences, Inc.
$247
Incyte Corporation
$237
Lilly USA, LLC
$176
PFIZER INC.
$139
Ortho Dermatologics, a division of Bausch Health US, LLC
$136
LEO Pharma Inc.
$82
SUN PHARMACEUTICAL INDUSTRIES INC.
$80
MAYNE PHARMA COMMERCIAL LLC
$12
Top 3 companies account for 39.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,908
Janssen Biotech, Inc.
$1,728
Regeneron Healthcare Solutions, Inc.
$1,638
GENZYME CORPORATION
$1,345
Amgen Inc.
$1,309
AbbVie Inc.
$1,161
Novartis Pharmaceuticals Corporation
$1,160
E.R. Squibb & Sons, L.L.C.
$1,095
PFIZER INC.
$990
Lilly USA, LLC
$909
Arcutis Biotherapeutics, Inc.
$868
AbbVie, Inc.
$860
Sun Pharmaceutical Industries Inc.
$831
Ortho Dermatologics, a division of Bausch Health US, LLC
$792
UCB, Inc.
$748
Incyte Corporation
$685
Galderma Laboratories, L.P.
$583
LEO Pharma Inc.
$467
Dermavant Sciences, Inc.
$354
Celgene Corporation
$246
MAYNE PHARMA INC.
$174
Mayne Pharma Inc.
$172
Merz North America, Inc.
$167
EPI Health, LLC
$160
DUSA Pharmaceuticals, Inc.
$141
Encore Dermatology Inc.
$133
VYNE Pharmaceuticals Inc.
$113
SUN PHARMACEUTICAL INDUSTRIES INC.
$104
Almirall LLC
$104
Allergan, Inc.
$92
Genentech USA, Inc.
$87
Paratek Pharmaceuticals, Inc.
$72
Sensus Healthcare, Inc.
$58
Journey Medical Corporation
$55
Promius Pharma LLC
$43
Taro Pharmaceuticals USA, Inc.
$39
DERMIRA, INC.
$36
MAYNE PHARMA COMMERCIAL LLC
$30
PruGen, Inc. Pharmaceuticals
$30
MERZ NORTH AMERICA, INC.
$22
Pierre Fabre Pharmaceuticals, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
TARO PHARMACEUTICALS USA, INC.
$13
Merck Sharp & Dohme Corporation
$12
Biofrontera Inc.
$7
Top 3 companies account for 24.4% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Acticlate · BOTOX · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DYSPORT · EBGLYSS · ENSTILAR · EPSOLAY · EUCRISA · Enbrel · Erivedge · Exelderm · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · NUZYRA · ODOMZO · ODOMZO (sonidegib) capsules · OLUMIANT · ONEXTON · OPZELURA · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOLODYN · SOOLANTRA · Sernivo · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TWYNEO · Tremfya · Trianex · VTAMA · Veltin · Winlevi · XELJANZ · XEOMIN · Xolair · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
70
County median income
$64,445
Nearest hospital to ZIP centroid (approximate)
UNC HOSPITALS
16.6 mi
16.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Benitez-Graham is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NC), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Benitez-Graham experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Benitez-Graham performed 1,562 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Benitez-Graham receive payments from pharmaceutical companies?
Yes. Dr. Benitez-Graham received a total of $21,573 from 45 companies across 1,269 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benitez-Graham's costs compare to other dermatologists in Mebane?
Dr. Benitez-Graham's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benitez-Graham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Mebane
Browse dermatologists in Mebane ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology